Journal of Liver Cancer

Case Report

Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure: Jaewoong Kim, Jin Won Chang, Jun Yong Park; J Liver Cancer. 2020;20(1):72-77. Published online March 31, 2020; DOI: https://doi.org/10.17998/jlc.20.1.72

6,962 Views
155 Downloads
4 Citations

Over the past decade, standard first-line systemic treatment of advanced hepatocellular carcinoma (HCC) has been based on sorafenib, a multi-kinase inhibitor. Regorafenib, another tyrosine kinase inhibitor, is the only second-line therapy that has been globally approved after progression under sorafenib treatment. Recently, immunotherapeutic agents have emerged as promising treatment options in many different malignancies, including advanced HCC. Nivolumab is the first immunotherapy approved by the Food and Drug Administration for use in HCC patients with advanced-stage second-line after sorafenib failure. In this report, a case of advanced HCC with multiple lung metastases in which a complete response and maintained progression-free status was achieved with nivolumab, following the failure of transarterial chemoembolization and sorafenib is presented. We hope this report may help expand the clinical application of second-line treatment.

Citations

Citations to this article as recorded by

Anticancer potential of Ampelopsis cantoniensis extract: Inducing apoptosis, cell cycle arrest, and targeting cancer stem cells in HepG2 liver cancer cells
Phu Hung Nguyen, Thi Thanh Huong Le, Dinh Quang Hung Can, Thi Ngoc Thuy Le, Viet Hoang, Hong Phuong Ngo, Thi Thu Huyen Do, Thi Kieu Oanh Nguyen, Van Hung Hoang
Biocatalysis and Agricultural Biotechnology.2025; 64: 103521. CrossRef
Mechanistic Insights into Nanomaterials and Advanced Drug Delivery Platforms for the Theranostic Management of Hepatic Cancer: A Comprehensive Update
Sagnik Nag, Yong Sze Ong, Kumaran Narayanan, Vetriselvan Subramaniyan, Rakesh Naidu
BioNanoScience.2025;[Epub] CrossRef
Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel Immunotherapies
Carlos A. Gallegos, Benjamin P. Lee, Benjamin B. Kasten, Jack M. Rogers, Carlos E. Cardenas, Jason M. Warram, James M. Markert, Anna G. Sorace
Cancers.2025; 17(19): 3176. CrossRef
Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
Ji Eun Han, Hyo Jung Cho, Soon Sun Kim, Jae Youn Cheong
Journal of Liver Cancer.2021; 21(2): 169. CrossRef

First
Prev
Page of 1
Next
Last

Search